drugset / Trial / NCT02711176
Comparison of Daily Single Dose Triple and Conventional Triple Therapies for Helicobacter Pylori Infection
RandomizedParallel-groupOpen-labelTreatment
Summary
This study is conducted to investigate whether the efficacy of single-dose triple therapy (Esomeprazole 40 mg, Tinidazole 1 g, and Levofluxacine 500 mg) for 14 days is superior to double-dose lansoprazole 30 mg, amoxicillin 1 g and clarithromycin 500 mg for 14 days in the treatment of H pylori infection.
Timeline
- Start
- 2016-09
- Primary completion
- 2017-03-27
- Completion
- 2017-03-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Amoxicillin | Other / unclassified | 1 g | — |
| Comparator | Clarithromycin | Small molecule | 500 mg | — |
| Subject | Esomeprazole | Small molecule | 40 mg | — |
| Comparator | Omeprazole | Other / unclassified | 30 mg | — |
| Subject | Tavanex | Unknown | 500 mg | — |
| Subject | tinidazole | Small molecule | 1 g | — |